Suppr超能文献

自体血小板浓缩物用于面部年轻化。

Autologous platelet concentrates for facial rejuvenation.

机构信息

Universidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Ciências Biológicas, Bauru, SP, Brasil.

出版信息

J Appl Oral Sci. 2022 Sep 5;30:e20220020. doi: 10.1590/1678-7757-2022-0020. eCollection 2022.

Abstract

BACKGROUND

Autologous platelet concentrates (APCs) are promising therapeutic agents in facial rejuvenation since they are a great source of cytokines, growth factors and other biologically active substances. Obtained from the patient's blood, they have the advantages of reducing immunological reactions, making the procedure safer, well tolerated, with minimal adverse effects and lower cost. Currently, they are used for facial rejuvenation both in combination with microneedling and in mesotherapy techniques, as well as to treat facial acne scars, melasma and wounds after laser ablative treatments. This review summarizes current knowledge on the use of APCs, ranging from basic concepts related to their composition and mechanisms of action to up-to-date information on their clinical efficacy.

METHODOLOGY

MEDLINE (PubMed) was searched from inception through 2021 for English language publications on APCs for facial rejuvenation.

RESULTS

A total of 100 files were found. Based on the available literature, APCs for skin rejuvenation are safe and well tolerated. The most studied product is the first-generation material, platelet-rich plasma (PRP).

CONCLUSIONS

The results are in general favorable, but the quality of the studies is low. The second and third generation products, platelet-rich fibrin (PRF) and injectable platelet-rich fibrin (i-PRF), respectively, are easier to be obtained and, at least in vitro , seem to induce greater collagen production than PRP, especially under lower relative centrifugation forces, but to date only a few clinical trials evaluating these products exist. More high-quality trials with appropriate follow-up are necessary to provide adequate evidence that may help to improve the treatment regimens with APCs. Many aspects should be considered when designing clinical trials to evaluate APCs, such as the patients' characteristics that best predict a favorable response, the optimal number of sessions and the interval between them, the characteristics of the studies and the development of better instruments to evaluate skin aging.

摘要

背景

自体血小板浓缩物(APCs)在面部年轻化中是一种很有前途的治疗药物,因为它们是细胞因子、生长因子和其他生物活性物质的重要来源。从患者的血液中提取,它们具有减少免疫反应的优点,使该过程更安全、耐受良好、不良反应最小、成本更低。目前,它们被用于面部年轻化,既与微针结合使用,也与中胚层疗法技术结合使用,还用于治疗面部痤疮疤痕、黄褐斑和激光消融治疗后的伤口。本综述总结了 APC 用于面部年轻化的最新知识,涵盖了从与 APC 组成和作用机制相关的基本概念到其临床疗效的最新信息。

方法

从建立到 2021 年,在 MEDLINE(PubMed)上搜索了有关 APC 用于面部年轻化的英文文献。

结果

共发现 100 篇文献。根据现有文献,用于皮肤年轻化的 APC 是安全且耐受良好的。研究最多的产品是第一代材料,富血小板血浆(PRP)。

结论

结果总体上是有利的,但研究质量较低。第二代和第三代产品,富血小板纤维蛋白(PRF)和可注射富血小板纤维蛋白(i-PRF),分别更容易获得,至少在体外,似乎比 PRP 诱导产生更多的胶原蛋白,尤其是在较低的相对离心力下,但迄今为止,只有少数评估这些产品的临床试验存在。需要更多高质量的、具有适当随访的试验,以提供足够的证据,从而有助于改善 APC 治疗方案。在设计临床试验评估 APC 时,应考虑许多方面,例如预测反应良好的患者特征、最佳治疗次数和间隔、研究特征以及开发更好的评估皮肤老化的仪器。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/9444188/7b644d67c437/1678-7757-jaos-30-e20220020-gf01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验